Skip to search boxSkip to navigationSkip to main content

Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban Ablation

  • Yoji Sato
    ,
  • Helen Kiriazis
    ,
  • Atsuko Yatani
    ,
  • Albrecht G. Schmidt
    ,
  • Harvey Hahn
    ,
  • Donald G. Ferguson
*Corresponding author for this work
  • National Institute of Health Sciences Tokyo
    ,
  • University of Cincinnati
    ,
  • Case Western Reserve University
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

<p>Cardiac-specific overexpression of murine cardiac calsequestrin results in depressed cardiac contractile parameters, low Ca<sup>2+</sup>-induced Ca <sup>2+</sup> release from sarcoplasmic reticulum (SR) and cardiac hypertrophy in transgenic mice. To test the hypothesis that inhibition of phospholamban activity may rescue some of these phenotypic alterations, the calsequestrin overexpressing mice were cross-bred with phospholamban-knockout mice. Phospholamban ablation in calsequestrin overexpressing mice led to reversal of the depressed cardiac contractile parameters in Langendorff-perfused hearts or in vivo. This was associated with increases of SR Ca<sup>2+</sup> storage, assessed by caffeine-induced Na<sup>+</sup>-Ca<sup>2+</sup> exchanger currents. The inactivation time of the L-type Ca<sup>2+</sup> current (I<sub>Ca</sub>) which has an inverse correlation with Ca<sup>2+</sup>-induced SR Ca <sup>2+</sup> release, and the relation between the peak current density and half-inactivation time were also normalized, indicating a restoration in the ability of I<sub>Ca</sub> to trigger SR Ca<sup>2+</sup> release. The prolonged action potentials in calsequestrin overexpressing cardiomyocytes also reversed to normal upon phospholamban ablation. Furthermore, ablation of phospholamban restored the expression levels of atrial natriuretic factor and α-skeletal actin mRNA as well as ventricular myocyte size. These results indicate that attenuation of phospholamban function may prevent or overcome functional and remodeling defects in hypertrophied hearts.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 9392-9399 (8 pages)

Journal (Volume, Issue Number)

Journal of Biological Chemistry (Volume 276, Issue 12)

Publication milestones

  • Published - 03/23/2001

Publication status

Published - 03/23/2001

ISSN

0021-9258

Publication IDs

  • Scopus: 0035937762
  • PubMed: 11115498

Publication metrics

Metrics

Fractional count
1
Fractional count
0.06
Fractional count
15
Fractional count
0.94
Fractional count
1
Fractional count
1
SciVal
citations
98
SciVal
FWCI
3.08
SciVal
Author count
16
SciVal
Paper percentile
93
SciVal
Top percentile
10
Scopus
citations

PlumX, opens in new tab

Captures
20
Citation count
97

Funding Details

FunderFunding number
NHLBI
R37HL026057